Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIRIVIMAB\IMDEVIMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

55.4%
Female
44.6%
Male

Age Information

The average age of patients reporting adverse events with CASIRIVIMAB\IMDEVIMAB is 54.3 years.

Geographic Distribution

The majority of adverse event reports for CASIRIVIMAB\IMDEVIMAB originate from US.

Report Summary & Outcomes

4,248
Total Reports
4,248
As Primary/Secondary Suspect
137
Deaths Reported
1,351
Hospitalizations
179
Life-Threatening
40
Disabilities

Reporting Timeline

First adverse event report: 19501117. Most recent report: 20230502. View full timeline →

More About CASIRIVIMAB\IMDEVIMAB

CASIRIVIMAB\IMDEVIMAB Full Profile Reports by Year Drug Interactions